B9- I am happy to share my opinions with all fellow shareholders. Always remember, my money rides along with my opinions. If my opinion changes, my investment in IMSC would quickly come to an end.
In terms of the Morpho/IMSC Director of Marketing swap ( call them cmo for chief marketing officer and dos for director of sales) . My answer is, it would make no difference to sales as of today as they both are well connected, both know buyer wants/needs and processes and both possess an elite contact list and both can make a call and have it taken on the other end. My view, today, right now, we have a director of marketing and sales that is as good as our French competitor.
And neither one can force a sale on a process that in reality is the sale. Nobody tells tsa what to buy but congress can sure mis-trigger when they buy.
Dr. Jones product insights/buyer habits and opinions have all helped shape IMSC products and more importantly IMSC sales presentations. So think about that. The IMSC cmo/dos and the Morpho cmo/dos flipped positions and similar presentations ( my guess) were made by both individuals yet neither has yielded etd sales from tsa. That is my confirmation that the sales-process is still in progress. Giving either of these fine cmo/dos' a failing grade would be premature, again, in my opinion.
While some IMSC shareholders dislike Dr. Jones now as cmo/dos for IMSC, I disliked him greatly when he handled the etd line of products at Morpho. I mean really disliked him in a professional sense. That's my 2 cent opinion as I see it.
Everything I have heard since posting here has not in any way deminished my opinion of my investment in IMSC.
Best of Luck to ALL IMSC LONGS!
